# Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products (Text with EEA relevance), Division 30

Extent: E+W+S+N.I.

With respect to skin sensitisation and respiratory sensitisation, in so far as there is no consensus on the possibility of identifying a dose/concentration below which adverse effects are unlikely to occur, particularly in a subject already sensitised to a given substance, it shall be sufficient to evaluate whether the active substance or substance of concern has an inherent capacity to cause such effects as a result of the use of the biocidal product.

---
Source: https://www.legislation.gov.uk/eur/2012/528/annex/VI/division/3/division/2/division/1/division/30 (the official version)
Page: https://openlegislation.uk/eu-regulation-2012-528/annex-VI/division-3/division-2/division-1/division-30
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.